ENLIVEN THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expenses, Other
ENLIVEN THERAPEUTICS, INC. (ELVN) reported Increase (Decrease) in Prepaid Expenses, Other of $513.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-05
- ENLIVEN THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was $2.16M, a 442.71% increase year-over-year.
- ENLIVEN THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was -$1.65M, a 1183.55% decline year-over-year.
- ENLIVEN THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was $694.00K.
- ENLIVEN THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was -$139.00K.
- ENLIVEN THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2025 was $1.10M, a 76.82% decline from fiscal 2024.
- ENLIVEN THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2024 was $4.77M, a 28.76% increase from fiscal 2023.
- ENLIVEN THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2023 was $3.70M, a 132.89% increase from fiscal 2022.
- ENLIVEN THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was $1.59M, a 576.60% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 3 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 6 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 9 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 12 month | Increase (Decrease) in Prepaid Expenses, Other 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $513.00K 10-Q · filed 2026-08-05 | $1.21M derived: sum of 3 quarters · filed 2026-08-05 | $1.07M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$1.65M 10-Q · filed 2026-05-07 | -$953.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.09M derived: sum of 3 quarters · filed 2026-05-07 | -$694.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $555.00K derived: sum of 2 quarters · filed 2026-03-03 | $953.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.10M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | -$139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $259.00K derived: sum of 2 quarters · filed 2026-08-05 | $411.00K 10-Q · filed 2025-11-12 | -$125.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $398.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $550.00K 10-Q · filed 2026-08-05 | $14.00K derived: sum of 3 quarters · filed 2026-08-05 | -$769.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $152.00K 10-Q · filed 2026-05-07 | -$384.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.17M derived: sum of 3 quarters · filed 2026-05-07 | $1.28M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$1.32M derived: sum of 2 quarters · filed 2026-03-03 | $1.13M derived: sum of 3 quarters · filed 2026-03-03 | $4.77M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | -$783.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.66M derived: sum of 2 quarters · filed 2025-11-12 | $5.30M 10-Q · filed 2025-11-12 | $3.58M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $2.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $6.09M 10-Q · filed 2025-08-13 | $4.37M derived: sum of 3 quarters · filed 2025-08-13 | $4.03M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $3.64M 10-Q · filed 2025-05-14 | $1.92M derived: sum of 2 quarters · filed 2025-05-14 | $1.58M derived: sum of 3 quarters · filed 2025-05-14 | $1.26M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$2.06M derived: sum of 2 quarters · filed 2025-03-13 | -$2.38M derived: sum of 3 quarters · filed 2025-03-13 | $3.70M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | -$337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$663.00K derived: sum of 2 quarters · filed 2024-11-13 | $5.42M 10-Q · filed 2024-11-13 | $5.50M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$326.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $5.76M 10-Q · filed 2024-08-13 | $5.84M derived: sum of 3 quarters · filed 2024-08-13 | $6.38M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $6.09M 10-Q · filed 2024-05-14 | $6.16M derived: sum of 2 quarters · filed 2024-05-14 | $6.71M derived: sum of 3 quarters · filed 2024-05-14 | $7.14M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $618.00K derived: sum of 2 quarters · filed 2024-03-14 | $1.05M derived: sum of 3 quarters · filed 2024-03-14 | $1.59M 10-K · filed 2024-03-14 | -$980.00K 10-K · filed 2023-02-10 | |||
| 2022-09-30 | $542.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $972.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.51M 10-Q · filed 2023-11-09 | $382.00K 10-Q · filed 2022-10-25 | $774.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $430.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $972.00K 10-Q · filed 2023-08-10 | $1.50M 10-Q · filed 2022-08-03 | $232.00K derived: sum of 3 quarters · filed 2023-08-10 | -$1.20M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $542.00K 10-Q · filed 2023-05-11 | $3.21M 10-Q · filed 2022-05-06 | -$198.00K derived: sum of 2 quarters · filed 2023-05-11 | -$1.63M derived: sum of 3 quarters · filed 2023-05-11 | -$1.81M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$740.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$2.17M derived: sum of 2 quarters · filed 2023-02-10 | -$2.35M derived: sum of 3 quarters · filed 2023-02-10 | $235.00K 10-K · filed 2023-02-10 | ||||
| 2021-09-30 | -$1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$1.61M derived: sum of 2 quarters · filed 2022-10-25 | $975.00K 10-Q · filed 2022-10-25 | -$465.00K derived: sum of 4 quarters · filed 2022-10-25 | ||||
| 2021-06-30 | -$180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.41M 10-Q · filed 2022-08-03 | $966.00K derived: sum of 3 quarters · filed 2022-08-03 | $270.00K derived: sum of 4 quarters · filed 2022-08-03 | ||||
| 2021-03-31 | $2.59M 10-Q · filed 2022-05-06 | $1.15M derived: sum of 2 quarters · filed 2022-05-06 | $450.00K derived: sum of 3 quarters · filed 2022-05-06 | $819.00K derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$2.14M derived: sum of 2 quarters · filed 2022-03-15 | -$1.77M derived: sum of 3 quarters · filed 2022-03-15 | $465.00K 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | -$696.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$327.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.91M 10-Q · filed 2021-11-09 | $2.36M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $2.60M 10-Q · filed 2021-08-06 | $3.06M derived: sum of 3 quarters · filed 2021-08-06 | $3.88M derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $2.23M 10-Q · filed 2021-05-11 | $2.69M derived: sum of 2 quarters · filed 2021-05-11 | $3.51M derived: sum of 3 quarters · filed 2021-05-11 | $3.79M derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | $458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $1.28M derived: sum of 2 quarters · filed 2021-03-05 | $1.55M derived: sum of 3 quarters · filed 2021-03-05 | $1.39M 10-K · filed 2021-03-05 | ||||
| 2019-09-30 | $822.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.10M derived: sum of 2 quarters · filed 2020-11-05 | $936.00K 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $275.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $114.00K 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | -$161.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |